Balyasny Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,357
| Closed | -$244K | – | 2887 |
|
|
2022
Q4 | $244K | Buy |
+7,357
| New | +$244K | ﹤0.01% | 1624 |
|
|
2021
Q4 | – | Sell |
-140,148
| Closed | -$2.7M | – | 2421 |
|
|
2021
Q3 | $2.7M | Buy |
140,148
+124,715
| +808% | +$2.4M | 0.01% | 854 |
|
|
2021
Q2 | $342K | Buy |
+15,433
| New | +$342K | ﹤0.01% | 1352 |
|
|
2020
Q3 | – | Sell |
-253,273
| Closed | -$5.9M | – | 1434 |
|
|
2020
Q2 | $5.9M | Buy |
253,273
+52,686
| +26% | +$1.23M | 0.05% | 404 |
|
|
2020
Q1 | $1.69M | Buy |
+200,587
| New | +$1.69M | 0.02% | 543 |
|
|
2016
Q4 | – | Sell |
-20,373
| Closed | -$393K | – | 1320 |
|
|
2016
Q3 | $393K | Sell |
20,373
-6,000
| -23% | -$116K | ﹤0.01% | 751 |
|
|
2016
Q2 | $514K | Sell |
26,373
-4,985
| -16% | -$97.2K | ﹤0.01% | 650 |
|
|
2016
Q1 | $646K | Buy |
31,358
+15,700
| +100% | +$323K | ﹤0.01% | 637 |
|
|
2015
Q4 | $321K | Buy |
+15,658
| New | +$321K | ﹤0.01% | 816 |
|